Metabasis Therapeutics, Inc (NASDAQ:MBRX)

Headlines for Metabasis Therapeutics, Inc

Metabasis Therapeutics Inc Reports Operating Results (10-Q)
GuruFocus.com - Nov 12, 2009
Metabasis Therapeutics, Inc. discovers and develops drugs for the treatment of liver diseases and metabolic diseases linked to pathways in the liver. They have established a broad pipeline of ...
Ligand Pharmaceuticals Announces Third Quarter Results
Reuters - Nov 5, 2009
http://www.businesswire.com/news/home/20091105006461/en Conference call with slide presentation begins at 4:30 pm Eastern time today SAN DIEGO--(Business Wire)-- Ligand Pharmaceuticals ...
Trading Outlook for Metabasis Therapeutics Issued by StockPreacher.com
StreetInsider.com - Oct 29, 2009
DALLAS, Oct. 29, 2009 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring Metabasis Therapeutics (Nasdaq: MBRX). The report includes financial and investment analysis ...
Daily Digest
San Diego Daily Transcript - Oct 28, 2009
Ligand Pharmaceuticals Inc. (Nasdaq: LGND) announced acquiring Metabasis Therapeutics Inc. (Nasdaq: MBRX) for $3.2 million in cash and Contingent Value Rights, and Helix Wind Corp. (OTC: HLXW ...
HLND, HPGP, JCI, MBRX, LGND, PALM, PCH, SLG Popular Stocks
Ub News - Oct 27, 2009
US stocks traded mixed Tuesday with the Dow Jones Industrial Average rose 14 points to 9882 but the S&P 500 down 4 points to 1063 and the Nasdaq composite down 26 points to 2116. Hiland Partners ...